Resources

Type of publications
Regions
Diseases

5192 results found

2012 ∙ El-Makhzangy, A. M. Ismail, N. M. Galal, S. B. Sobhy, T. S. Hegazy, A. A.

Can vaccination against pneumococci prevent otitis media with effusion?

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2012 ∙ Bar-On, E. S. Goldberg, E. Hellmann, S. Leibovici, L.

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)

  • Newborn
  • Children
  • Diphtheria
  • Tetanus
  • Pertussis
  • Hepatitis B
  • Haemophilus influenzae type B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2012 ∙ Ozawa, S. Mirelman, A. Stack, M. L. Walker, D. G. Levine, O. S.

Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review

  • All age groups
  • Low and Middle Income Countries
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2012 ∙ Farkouh, R. A. Klok, R. M. Postma, M. J. Roberts, C. S. Strutton, D. R.

Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions

  • All age groups
  • Pneumococcal disease
  • Economic aspects
  • Coverage
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2012 ∙ Malagón, T. Drolet, M. Boily, M. C. Franco, E. L. Jit, M. Brisson, J. Brisson, M.

Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2012 ∙ Griffiths, U. K. Clark, A. Gessner, B. Miners, A. Sanderson, C. Sedyaningsih, E. R. Mulholland, K. E.

Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta- Analysis of controlled clinical trials

  • Newborn
  • Children
  • Haemophilus influenzae type B
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2012 ∙ Kuo, A. M. Brown, J. N. Clinard, V.

Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy

  • All age groups
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2012 ∙ Manzoli, L. Ioannidis, J. P. Flacco, M. E. De Vito, C. Villari, P.

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2012 ∙ Osterholm, M. T. Kelley, N. S. Sommer, A. Belongia, E. A.

Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis

  • Americas
  • United States of America
  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2012 ∙ Rey-Ares, L. Ciapponi, A. Pichon-Riviere, A.

Efficacy and safety of human papilloma virus vaccine in cervical cancer prevention: systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...